Newstral
Article
Mmarketwatch.com on 2022-12-12 21:08
Amgen wins battle for Horizon Therapeutics, bolstering its rare-disease portfolio2 min read
Related news
- Amgen to buy Horizon Therapeutics in $26.4-billion dealLA Times
- Amgen to buy Horizon Therapeutics in $26.4 billion dealdailyherald.com
- Amgen to buy Horizon Therapeutics in $26.4B dealThe Wichita Eagle
- THorizon Therapeutics Stock Surges On $28.5 Billion Amgen Takeoverthestreet.com
- Amgen in Thousand Oaks buying Horizon Therapeutics for $28 billiondailynews.com
- Biotech: Amgen to buy Horizon Therapeutics for $28.3bnFinancial Times
- Health: Amgen close to deal to buy Horizon Therapeutics for $20bnFinancial Times
- BAmgen to Buy Horizon Therapeutics for $116.50 a Share1 min readbarrons.com
- Biotech company Amgen to buy drug firm HorizonArkansas Online
- PAmgen to buy Horizon for $27 billion in cashpacbiztimes.com
- BAmgen in Advanced Talks to Buy Horizon Therapeutics1 min readbarrons.com
- M50 new jobs as Horizon Therapeutics buys EirGen’s Waterford plantmunster-express.ie
- PAmgen buys Horizon Therapeutics for $27Bpacbiztimes.com
- Amgen settles with FTC on $27.8 billion Horizon takeover - Fri, 01 Sep 2023 PSTsyndication.washingtonpost.com